Trending: Avoid the #1 Investing Mistake: How Your 'Safe' Holdings Could Be Costing You Big Time GLP-1 Drugs Fuel Pharma Growth Companies like Eli Lilly have capitalized on this trend, with their revenue soaring 56% year-over-year to $19.8 billion during its first-quarter 2026, driven primarily by the astronomical volume demand for its metabolic and weight-management medications
Growing evidence from randomized controlled trials, dramatic patient and provider reports, and patient health record studies shows a strong reduction in smoking for people taking GLP-1 medications like Ozempic, Wegovy, Mounjaro, or Zepbound
If necessary, it can later be increased to 300-500mcg
doi: 10.1001/jamanetworkopen.2020.33457 144 PetricoulONazarianASchuehlyUSchrammUDavidOJLaurentDet al
We may also recommend additional services such as nutritional counseling, exercise programs, or even medication-assisted weight loss, such as the new injectable medication Wegovy